(AFP Photo/Fabrice COFFRINI / MANILA BULLETIN)
Department of Science and Technology Undersecretary Rowena Cristina Guevara, who leads the Task Group on Vaccine Evaluation and Selection (TG-VES), said the SOPs and protocols will be given to the Philippine government by the third week of February.
“We will get in two weeks’ time,” she told the Manila Bulletin in a phone interview.
“Kasi inexplain nila sa amin kasi biglang nagkaroon ng variants ‘yung UK and South Africa, they also had to figure out how to understate the protocol,”she said.
(They explained to us, because we suddenly had the UK and South Africa , they also had to figure out how to understate the protocol.)
(photo from AFP)
Department of Science and Technology Undersecretary Rowena Cristina Guevara, who heads the task group, noted the level of interest among the LGUs and healthcare workers on the clinical trials.
“We are getting their support,” she told the Manila Bulletin in a phone interview when asked about the results of the town hall meetings conducted by the TG-VES, in cooperation with the Task Group Demand Generation and Communication.
“It is not acceptance of vaccines, but rather understanding the information so that they can explain dun sa babakunahan nila at dun sa magpa-participate sa ating clinical trials. Natutuwa kami, when we started last January 29 there were more than 500 participants,and Monday, more than 900 participants at makita mo ang level ng interest, kasi when we started Monday, hindi pa kami nagu-umpisa 300 questions na ((It is not acceptance of vaccines, but rather understanding the information so that they can explain to the recipients of v
Department of Science and Technology Secretary Fortunato dela Peña
(TOTO LOZANO / Presidential Photo / MANILA BULLETIN FILE PHOTO)
DOST Secretary Fortunato dela Peña said the Indian biotechnology company has yet to submit the requirements for clinical trials amid its recent signing of a Confidentiality Disclosure Agreement (CDA) with the Task Group on Vaccine Evaluation and Selection.
“A CDA with Bharat Biotech for their clinical trial in the Philippines was recently signed. Submission of their requirements for clinical trial is being awaited which will be evaluated by the Vaccine Expert Panel and Ethics Board before it is given to FDA for approval,” he told the Manila Bulletin.
Published January 28, 2021, 5:58 PM
Aimed at addressing vaccine hesitancy, three town hall meetings on the conduct of the World Health Organization (WHO) Solidarity Vaccine Trials (SVT) have been scheduled starting tomorrow, January 29, Department of Science and Technology (DoST) Secretary Fortunato dela Peña said Thursday.
(Photo by Mladen ANTONOV / AFP / FILE PHOTO / MANILA BULLETIN)
The DoST top official said that the Task Group on Vaccine Evaluation and Selection (TG-VES), in cooperation with the Task Group Demand Generation and Communication, have organized the town hall meetings “specific on clinical trials.”
The DoST chairs the TG-VES.
He said tomorrow’s town hall meetings at 4 p.m. will benefit leaders of local government units (LGUs) in trial sites. These include local chief executives and barangay captains.
A Confidentiality Disclosure Agreement (CDA) has been signed by the Task Group on Vaccine Evaluation and Selection with German company Curevac, Department of Science and Technology (DoST) Secretary Fortunato dela Pena said Friday.